Methyl Alcohol

Methyl Alcohol

SCHEMBL6900401

CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC.CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.69
OXER1 Q8TDS5 1/20 0.69
MGLL Q99685 1/20 0.65
CNR1 P21554 6/20 0.64
CNR2 P34972 2/20 0.64
ALDH1A1 P00352 3/20 0.64
MAPT P10636 3/20 0.64
PPARG P37231 2/20 0.64
HPGD P15428 2/20 0.64
KDM4E B2RXH2 1/20 0.64
MEN1 O00255 1/20 0.64
USP2 O75604 1/20 0.64
LMNA P02545 1/20 0.64
TP53 P04637 1/20 0.64
CYP3A4 P08684 1/20 0.64
HSPD1 P10809 1/20 0.64
CYP19A1 P11511 1/20 0.64
FABP4 P15090 1/20 0.64
ALOX15 P16050 1/20 0.64
CASP1 P29466 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL6900398 1.00 ALOX5 (0.69) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL7885020 0.98 ALOX5 (0.71) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL23821 0.98 ALOX5 (0.71) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL29253889 0.98 ALOX5 (0.71) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL23820 0.98 ALOX5 (0.71) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL23152374 0.98 ALOX5 (0.71) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL7885017 0.98 ALOX5 (0.71) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL32662839 0.97 ALOX5 (0.69) ALOX5OXER1MGLLCNR1CNR2
SCHEMBL23143237 0.95 ALOX5 (0.71) ALOX5OXER1MGLLALDH1A1PPARG
SCHEMBL7170526 0.95 ALOX5 (0.71) ALOX5OXER1MGLLALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0926951-B1 TREATING PULMONARY DISEASES MEDIATED BY POLYUNSATURATED LIPID METABOLITES AND ASSAYS FOR EPOXIDE HYDROLASE INHIBITORS UNIV CALIFORNIA (US) 2004-04-21 EP claimed